Novo Nordisk has announced the launch of ‘Cities Changing Diabetes’, a new partnership program to fight the urban diabetes challenge.
Initially, the program will be launched in Mexico City with other cities in North America, Europe and Asia soon to follow. “The global diabetes epidemic is an emergency in slow motion. While there are many factors fuelling the growth trajectory of diabetes, the most striking contributor is urbanisation and the growth of cities. The ‘Cities Changing Diabetes’ programme is our call to arms for people around the world to work together to tackle this for the long-term,” said Lars Rebien Sørensen, chief executive officer, Novo Nordisk, in a press release.
The aim of the program is according to Novo Nordisk to map the problem, share solutions and drive concrete action to fight the diabetes challenge in the big cities around the world. The program will be developed in partnership with University College London (UCL) and supported by Steno Diabetes Center, Denmark, a world-leading institution in diabetes care and prevention, as well as a range of local partners including healthcare professionals, city authorities, urban planners, businesses, academics and community leaders, amongst others.
